Page 65 - 南京医科大学学报自然科学版
P. 65
第43卷第5期 陆嘉宁,马 佩,高 雯,等. 75岁以上癌症患者免疫治疗相关不良反应的回顾性分析[J].
2023年5月 南京医科大学学报(自然科学版),2023,43(5):640-647 ·647 ·
[38] GANDHI L,RODRIGUEZ⁃ABREU D,GADGEEL S,et can society of clinical oncology clinical practice guideline
al. Pembrolizumab plus chemotherapy in metastatic non⁃ [J]. J Clin Oncol,2018,36(17):1714-1768
small⁃cell lung cancer[J]. N Engl J Med,2018,378(22): [42] NOSAKI K,SAKA H,HOSOMI Y,et al. Safety and effica⁃
2078-2092 cy of pembrolizumab monotherapy in elderly patients with
[39] PAZ⁃ARES L,LUFT A,VICENTE D,et al. Pembrolizum⁃ PD ⁃ L1 ⁃ positive advanced non ⁃ small ⁃ cell lung cancer:
ab plus chemotherapy for squamous non⁃small⁃cell lung Pooled analysis from the KEYNOTE ⁃ 010,KEYNOTE ⁃
cancer[J]. N Engl J Med,2018,379(21):2040-2051 024,and KEYNOTE⁃042 studies[J]. Lung Cancer,2019,
[40] SOCINSKI M A,JOTTE R M,CAPPUZZO F,et al. 135:188-195
Atezolizumab for first ⁃ line treatment of metastatic non⁃ [43] SATTAR J,KARTOLO A,HOPMAN W M,et al. The effi⁃
squamous NSCLC[J]. N Engl J Med,2018,378(24): cacy and toxicity of immune checkpoint inhibitors in a re⁃
2288-2301 al ⁃ world older patient population[J]. J Geriatr Oncol,
[41] BRAHMER J R,LACCHETTI C,SCHNEIDER B J,et al. 2019,10(3):411-414
Management of immune⁃related adverse events in patients [收稿日期] 2023-01-30
treated with immune checkpoint inhibitor therapy:Ameri⁃ (本文编辑:唐 震)
(上接第603页) prognosis of patients with liver cancer[J]. Oncoimmunolo⁃
PD⁃L1 表达的影响[J].南京医科大学学报(自然科学 gy,2017,6(1):e1264562
版),2021,41(4):503-508 [68] LI F,WEI H,WEI H,et al. Blocking the natural killer
[65] GE Z,ZHOU G,CAMPOS CARRASCOSA L,et al. TIGIT cell inhibitory receptor NKG2A increases activity of hu⁃
and PD1 co⁃blockade restores ex vivo functions of human man natural killer cells and clears hepatitis B virus infec⁃
tumor⁃infiltrating CD8(+)T cells in hepatocellular carci⁃ tion in mice[J]. Gastroenterology,2013,144(2):392-
noma[J]. Cell Mol Gastroenterol Hepatol,2021,12(2): 401
443-464 [69] BATTIN C,KAUFMANN G,LEITNER J,et al. NKG2A⁃
[66] MCGRANAHAN N,ROSENTHAL R,HILEY C T,et al. checkpoint inhibition and its blockade critically depends
Allele⁃specific HLA loss and immune escape in lung can⁃ on peptides presented by its ligand HLA⁃E[J]. Immunolo⁃
cer evolution[J]. Cell,2017,171(6):1259-1271 gy,2022,166(4):507-521
[67] SUN C,XU J,HUANG Q,et al. High NKG2A expression [收稿日期] 2023-02-11
contributes to NK cell exhaustion and predicts a poor (本文编辑:唐 震)